oxamniquine has been researched along with N-[2-(1-azepanyl)-1,3-benzothiazol-6-yl]carbamic acid ethyl ester in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballante, F; Marshall, GR; Reddy, DR; Zhou, NJ | 1 |
1 other study(ies) available for oxamniquine and N-[2-(1-azepanyl)-1,3-benzothiazol-6-yl]carbamic acid ethyl ester
Article | Year |
---|---|
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.
Topics: Animals; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; In Vitro Techniques; Molecular Docking Simulation; Molecular Structure; Quantitative Structure-Activity Relationship; Schistosoma mansoni | 2017 |